Profil
Derek Hicks currently works at Rezo Therapeutics, Inc., as Chief Executive Officer from 2025.
Mr. Hicks also formerly worked at Spark Therapeutics, Inc., as Head-Business Development from 2020 to 2021 and Intellia Therapeutics, Inc., as Chief Business Officer & Executive Vice President.
Mr. Hicks received his undergraduate degree and graduate degree from the University of Connecticut and Masters Business Admin degree from Kelley School of Business.
Aktive Positionen von Derek Hicks
| Unternehmen | Position | Beginn |
|---|---|---|
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Vorstandsvorsitzender | 12.08.2025 |
Ehemalige bekannte Positionen von Derek Hicks
| Unternehmen | Position | Ende |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2021 |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Derek Hicks
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
















